Skip to main content
. 2019 Mar 25;10(3):312–323. doi: 10.1177/2192568219837923

Figure 2.

Figure 2.

VAS baseline scores compared to 3-month follow-up (−2.94 [95% CI: −3.67 to −2.21]; heterogeneity: I2 = 99.7%, P < .001).